Rapamycin inhibition of polyposis and progression to dysplasia in a mouse model.
Familial adenomatous polyposis (FAP) is often due to adenomatous polyposis coli (APC) gene germline mutations. Somatic APC defects are found in about 80% of colorectal cancers (CRCs) and adenomas. Rapamycin inhibits mammalian target of rapamycin (mTOR) protein, which is often expressed in human aden...
Guardado en:
Autores principales: | Karin M Hardiman, Jianhua Liu, Ying Feng, Joel K Greenson, Eric R Fearon |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bc62b423af1d46478dfd2895a237726f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rapamycin adjuvant and exacerbation of severe influenza in an experimental mouse model
por: Ching-Tai Huang, et al.
Publicado: (2017) -
Porcine familial adenomatous polyposis model enables systematic analysis of early events in adenoma progression
por: Tatiana Flisikowska, et al.
Publicado: (2017) -
The effect of a ketogenic diet and synergy with rapamycin in a mouse model of breast cancer.
por: Yiyu Zou, et al.
Publicado: (2020) -
Rapamycin attenuates the development of posttraumatic epilepsy in a mouse model of traumatic brain injury.
por: Dongjun Guo, et al.
Publicado: (2013) -
Inhibiting the Mammalian Target of Rapamycin Blocks the Development of Experimental Cerebral Malaria
por: Emile B. Gordon, et al.
Publicado: (2015)